Latest Umbilical cord Stories
LAS VEGAS, Dec. 27, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce it has signed an exclusive agreement to store stem cells at its Las Vegas laboratory for the National Children's Leukemia Foundation (NCLF), New York. "The National...
HONG KONG, Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest umbilical cord blood banking operator in China, today announced the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong. At the Annual General Meeting, shareholders Elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of Directors until the 2014 Annual General Meeting of the...
COVINA, Calif., Dec. 13, 2011 /PRNewswire/ -- Renowned experts in cord blood collection, processing and transplantation have joined StemCyte, Inc. The added resources are evidence of its commitment as a worldwide industry leader in developing and providing the safest and most effective cord blood therapies for treating patients. Dr. Wise Young MD PhD has agreed to join StemCyte as its Global Medical Director. He will serve in a voluntary (unpaid) and part-time capacity to...
A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I clinical trial led by Dana-Farber Cancer Institute scientists indicates. Details of the trial (abstract 653), which involved 12 patients who underwent reduced-intensity chemotherapy and then received a transplant of cord blood stem cells treated with the compound FT1050, will be presented at...
Technique expands scarce resources used for cord blood transplant procedure A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 53rd American...
LAS VEGAS, Dec. 8, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that co-founder and CEO Matthew Schissler was interviewed by analyst Francis Gaskins about the Company's 2011 financial performance. The entire interview is available at:...
HONG KONG, Nov. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2012 on Monday, November 28, 2011, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 29, 2011 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question...
Researchers have identified a potential marker for leukemic relapse The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse. The researchers' findings, published recently in Blood,...
LAS VEGAS, Nov. 17, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today is pleased to announce that it has been notified by The Depository Trust & Clearing Corp. that the "chill" announced by the DTCC in December 2010 has been removed. About Cord Blood America Cord Blood...
According to new research, waiting at least three minutes before clamping the umbilical cord of a newborn baby improves their iron levels at four months. The study said that delaying cord clamping is not linked to neonatal jaundice or other adverse health effects and should be standard care after uncomplicated pregnancies. Although other research indicates that delayed cord clamping could prevent iron deficiency, these studies had conflicting results regarding the risk of neonatal...
